{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T12:50:06Z","timestamp":1795006206359,"version":"4.9.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["72190278"],"award-info":[{"award-number":["72190278"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FI21\/00262"],"award-info":[{"award-number":["FI21\/00262"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00130"],"award-info":[{"award-number":["PI20\/00130"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["2021 SGR 00459"],"award-info":[{"award-number":["2021 SGR 00459"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["2021 SGR 00459"],"award-info":[{"award-number":["2021 SGR 00459"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["2021 SGR 00459"],"award-info":[{"award-number":["2021 SGR 00459"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The gut microbiome plays a key role in the development of inflammatory bowel disease (IBD), as imbalances in microbial composition are associated with immune dysfunction. However, the specific mechanisms by which certain microorganisms contribute to this process remain unclear.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Here, we employed a multi-omics approach on fecal samples to identify novel microbiome markers and elucidate mechanisms underlying IBD. Shotgun metagenomics was applied to 212 samples (850 in total with validation cohort), shotgun metatranscriptomics to 103 samples and metabolomics to 105 samples. Machine learning techniques were used to predict disease and the three omics data were integrated to propose a mechanistic role of the microbiota.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Metagenomic analysis identified Crohn's disease (CD)-specific microbiome signatures, including a panel of 20 species that achieved a high diagnostic performance, with an area under the ROC curve (AUC) of 0.94 in an external validation set. Metatranscriptomic analysis revealed significant alterations in microbial fermentation pathways in CD, but not in ulcerative colitis (UC), highlighting disruptions that explain the depletion of butyrate\u2014a key anti-inflammatory metabolite\u2014observed in metabolomics analysis. Integrative multi-omics analyses further identified active virulence factor genes in CD, predominantly originating from the adherent-invasive <jats:italic>Escherichia coli<\/jats:italic> (AIEC). Notably, these findings unveiled novel mechanisms, including E. coli-mediated aspartate depletion and the utilization of propionate, which drives the expression of the ompA virulence gene, critical for bacterial adherence and invasion of the host\u2019s macrophages. Interestingly, these microbiome alterations were absent in UC, underscoring distinct mechanisms of disease development between the two IBD subtypes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>In conclusion, our study not only identifies promising novel biomarkers with strong diagnostic potential, which could be valuable in challenging clinical scenarios, but also offers an integrated multi-omics perspective on the microbial mechanisms underlying inflammation and virulence in Crohn's disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40364-025-00802-1","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T17:57:27Z","timestamp":1750096647000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Microbiome multi-omics analysis reveals novel biomarkers and mechanisms linked with CD etiopathology"],"prefix":"10.1186","volume":"13","author":[{"given":"Gerard","family":"Serrano-G\u00f3mez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Ya\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaida","family":"Soler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Pons-Tarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Mayorga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Herrera-deGuise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Borruel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Rodriguez-Sinovas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Consegal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Manj\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Vega-Abellaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaysavanh","family":"Manichanh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"802_CR1","doi-asserted-by":"publisher","unstructured":"Carvalho FA, et al. Crohn\u2019s disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM. J Exp Med. 2009. https:\/\/doi.org\/10.1084\/jem.20090741.","DOI":"10.1084\/jem.20090741"},{"key":"802_CR2","doi-asserted-by":"publisher","unstructured":"Nadalian B, et al. Prevalence of the pathobiont adherent-invasive Escherichia coli and inflammatory bowel disease: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2021. https:\/\/doi.org\/10.1111\/jgh.15260.","DOI":"10.1111\/jgh.15260"},{"key":"802_CR3","doi-asserted-by":"publisher","unstructured":"Schmitz JM, et al. Murine Adherent and invasive E. coli induces chronic inflammation and immune responses in the small and large intestines of monoassociated IL-10-\/- mice independent of long polar fimbriae adhesin A. Inflamm Bowel Dis. 2019. https:\/\/doi.org\/10.1093\/ibd\/izy386.","DOI":"10.1093\/ibd\/izy386"},{"key":"802_CR4","doi-asserted-by":"publisher","unstructured":"Darfeuille-Michaud A, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn\u2019s disease. Gastroenterology. 1998. https:\/\/doi.org\/10.1016\/s0016-5085(98)70019-8.","DOI":"10.1016\/s0016-5085(98)70019-8"},{"key":"802_CR5","doi-asserted-by":"publisher","unstructured":"Nagayama M, et al. TH1 cell-inducing Escherichia coli strain identified from the small intestinal mucosa of patients with Crohn\u2019s disease. Gut Microbes. 2020. https:\/\/doi.org\/10.1080\/19490976.2020.1788898.","DOI":"10.1080\/19490976.2020.1788898"},{"key":"802_CR6","doi-asserted-by":"publisher","unstructured":"Viladomiu M, et al. Adherent-invasive E. coli metabolism of propanediol in Crohn's disease regulates phagocytes to drive intestinal inflammation. Cell Host Microbe. 2021. https:\/\/doi.org\/10.1016\/j.chom.2021.01.002.","DOI":"10.1016\/j.chom.2021.01.002"},{"key":"802_CR7","doi-asserted-by":"publisher","unstructured":"Canani RB, et al. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol. 2011. https:\/\/doi.org\/10.3748\/wjg.v17.i12.1519.","DOI":"10.3748\/wjg.v17.i12.1519"},{"key":"802_CR8","doi-asserted-by":"publisher","unstructured":"Hodgkinson K, et al. Butyrate\u2019s role in human health and the current progress towards its clinical application to treat gastrointestinal disease. Clin Nutr. 2023. https:\/\/doi.org\/10.1016\/j.clnu.2022.10.024.","DOI":"10.1016\/j.clnu.2022.10.024"},{"key":"802_CR9","doi-asserted-by":"publisher","unstructured":"Ormsby MJ, et al. Propionic Acid Promotes the Virulent Phenotype of Crohn\u2019s Disease-Associated Adherent-Invasive Escherichia coli. Cell Rep. 2020. https:\/\/doi.org\/10.1016\/j.celrep.2020.01.078.","DOI":"10.1016\/j.celrep.2020.01.078"},{"key":"802_CR10","doi-asserted-by":"publisher","unstructured":"Pobeguts OV, et al. Propionate Induces Virulent Properties of Crohn\u2019s Disease-Associated Escherichia coli. Front Microbiol. 2020. https:\/\/doi.org\/10.3389\/fmicb.2020.01460.","DOI":"10.3389\/fmicb.2020.01460"},{"key":"802_CR11","doi-asserted-by":"publisher","unstructured":"Agus A, et al. Propionate catabolism by CD-associated adherent-invasive E. coli counteracts its anti-inflammatory effect. Gut Microbes. 2021; https:\/\/doi.org\/10.1080\/19490976.2020.1839318.","DOI":"10.1080\/19490976.2020.1839318"},{"key":"802_CR12","doi-asserted-by":"publisher","unstructured":"Pascal V, et al. A microbial signature for Crohn\u2019s disease. Gut. 2017. https:\/\/doi.org\/10.1136\/gutjnl-2016-313235.","DOI":"10.1136\/gutjnl-2016-313235"},{"key":"802_CR13","doi-asserted-by":"publisher","unstructured":"Xie Z, et al. Shotgun metagenomics reveals interkingdom association between intestinal bacteria and fungi involving competition for nutrients. Microbiome. 2023. https:\/\/doi.org\/10.1186\/s40168-023-01693-w.","DOI":"10.1186\/s40168-023-01693-w"},{"key":"802_CR14","doi-asserted-by":"publisher","unstructured":"Cardona S, et al. Storage conditions of intestinal microbiota matter in metagenomic analysis. BMC Microbiol. 2012. https:\/\/doi.org\/10.1186\/1471-2180-12-158.","DOI":"10.1186\/1471-2180-12-158"},{"key":"802_CR15","doi-asserted-by":"publisher","unstructured":"Lamichhane S, et al. Strategy for Nuclear-Magnetic-Resonance-Based Metabolomics of Human Feces. Anal Chem. 2015. https:\/\/doi.org\/10.1021\/acs.analchem.5b00977.","DOI":"10.1021\/acs.analchem.5b00977"},{"key":"802_CR16","doi-asserted-by":"publisher","unstructured":"Le Gall G, et al. Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res. 2011. https:\/\/doi.org\/10.1021\/pr2003598.","DOI":"10.1021\/pr2003598"},{"key":"802_CR17","doi-asserted-by":"publisher","unstructured":"Blanco-Miguez A, et al. Extending and improving metagenomic taxonomic profiling with uncharacterized species using MetaPhlAn 4. Nat Biotechnol. 2023. https:\/\/doi.org\/10.1038\/s41587-023-01688-w.","DOI":"10.1038\/s41587-023-01688-w"},{"key":"802_CR18","doi-asserted-by":"publisher","unstructured":"Beghini F, et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. Elife. 2021. https:\/\/doi.org\/10.7554\/eLife.65088.","DOI":"10.7554\/eLife.65088"},{"key":"802_CR19","doi-asserted-by":"publisher","unstructured":"Liu B, et al. VFDB 2022: a general classification scheme for bacterial virulence factors. Nucleic Acids Res. 2022; https:\/\/doi.org\/10.1093\/nar\/gkab1107.","DOI":"10.1093\/nar\/gkab1107"},{"key":"802_CR20","doi-asserted-by":"publisher","unstructured":"Lin H, Peddada SD. Analysis of compositions of microbiomes with bias correction. Nat Commun. 2020. https:\/\/doi.org\/10.1038\/s41467-020-17041-7.","DOI":"10.1038\/s41467-020-17041-7"},{"key":"802_CR21","doi-asserted-by":"publisher","unstructured":"Thevenot EA, et al. Analysis of the Human Adult Urinary Metabolome Variations with Age, Body Mass Index, and Gender by Implementing a Comprehensive Workflow for Univariate and OPLS Statistical Analyses. J Proteome Res. 2015. https:\/\/doi.org\/10.1021\/acs.jproteome.5b00354.","DOI":"10.1021\/acs.jproteome.5b00354"},{"key":"802_CR22","doi-asserted-by":"publisher","unstructured":"Harber KJ, et al. Succinate Is an Inflammation-Induced Immunoregulatory Metabolite in Macrophages. Metabolites. 2020. https:\/\/doi.org\/10.3390\/metabo10090372.","DOI":"10.3390\/metabo10090372"},{"key":"802_CR23","doi-asserted-by":"publisher","unstructured":"Macias-Ceja DC, et al. Succinate receptor mediates intestinal inflammation and fibrosis. Mucosal Immunol. 2019. https:\/\/doi.org\/10.1038\/s41385-018-0087-3.","DOI":"10.1038\/s41385-018-0087-3"},{"key":"802_CR24","doi-asserted-by":"publisher","unstructured":"Tannahill GM, et al. Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha. Nature. 2013. https:\/\/doi.org\/10.1038\/nature11986.","DOI":"10.1038\/nature11986"},{"key":"802_CR25","doi-asserted-by":"publisher","unstructured":"Ning L, et al. Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts. Nat Commun. 2023. https:\/\/doi.org\/10.1038\/s41467-023-42788-0.","DOI":"10.1038\/s41467-023-42788-0"},{"key":"802_CR26","doi-asserted-by":"publisher","unstructured":"Pi D, et al. Dietary supplementation of aspartate enhances intestinal integrity and energy status in weanling piglets after lipopolysaccharide challenge. J Nutr Biochem. 2014. https:\/\/doi.org\/10.1016\/j.jnutbio.2013.12.006.","DOI":"10.1016\/j.jnutbio.2013.12.006"},{"key":"802_CR27","doi-asserted-by":"publisher","unstructured":"Wang H, et al. Aspartate attenuates intestinal injury and inhibits TLR4 and NODs\/NF-kappaB and p38 signaling in weaned pigs after LPS challenge. Eur J Nutr. 2017. https:\/\/doi.org\/10.1007\/s00394-016-1189-x.","DOI":"10.1007\/s00394-016-1189-x"},{"key":"802_CR28","doi-asserted-by":"publisher","unstructured":"Halfvarson J, et al. Dynamics of the human gut microbiome in inflammatory bowel disease. Nat Microbiol. 2017. https:\/\/doi.org\/10.1038\/nmicrobiol.2017.4.","DOI":"10.1038\/nmicrobiol.2017.4"},{"key":"802_CR29","doi-asserted-by":"publisher","unstructured":"Serrano-Gomez G, et al. Dysbiosis and relapse-related microbiome in inflammatory bowel disease: A shotgun metagenomic approach. Comput Struct Biotechnol J. 2021. https:\/\/doi.org\/10.1016\/j.csbj.2021.11.037.","DOI":"10.1016\/j.csbj.2021.11.037"},{"key":"802_CR30","doi-asserted-by":"publisher","unstructured":"Krueger ME, et al. Comparative analysis of Parkinson\u2019s and inflammatory bowel disease gut microbiomes reveals shared butyrate-producing bacteria depletion. NPJ Parkinsons Dis. 2025. https:\/\/doi.org\/10.1038\/s41531-025-00894-4.","DOI":"10.1038\/s41531-025-00894-4"},{"key":"802_CR31","doi-asserted-by":"publisher","unstructured":"Kostic AD, et al. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology. 2014. https:\/\/doi.org\/10.1053\/j.gastro.2014.02.009.","DOI":"10.1053\/j.gastro.2014.02.009"},{"key":"802_CR32","doi-asserted-by":"publisher","unstructured":"Lloyd-Price J, et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature. 2019. https:\/\/doi.org\/10.1038\/s41586-019-1237-9.","DOI":"10.1038\/s41586-019-1237-9"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-025-00802-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40364-025-00802-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-025-00802-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T17:57:28Z","timestamp":1750096648000},"score":1,"resource":{"primary":{"URL":"https:\/\/biomarkerres.biomedcentral.com\/articles\/10.1186\/s40364-025-00802-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["802"],"URL":"https:\/\/doi.org\/10.1186\/s40364-025-00802-1","relation":{},"ISSN":["2050-7771"],"issn-type":[{"value":"2050-7771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"assertion":[{"value":"4 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study involves human participants and was approved by the local Ethics Committee of the Vall d\u2019Hebron University Hospital, Barcelona (Project identification code: PR(AG)84\/2020). All participants signed a consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants consented independently when donating samples. All data obtained and generated during the study were kept confidential.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"85"}}